Overview

Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
0
Participant gender:
All
Summary
Prophylactic use of tranexamic acid to reduce intra and postoperative bleeding in primary sleeve gastrectomy procedures will be studied.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sheba Medical Center
Treatments:
Tranexamic Acid
Criteria
Inclusion Criteria:

- Morbid obesity

- Approved and scheduled for laparoscopic sleeve gastrectomy

Exclusion Criteria:

- Previous bariatric surgery

- Platelet count under 100,000

- Concurrent anticoagulation treatment

- Previous venous/atrerial thromboembolic event

- Known allergy to tranexamic acid

- History of heparin induced thrombocytopenia

- Oral contraceptive use

- Female hormonal replacement therapy

- Active thromboembolic state

- Genetic hypercoagulable state